David Planchard, Thoracic Pathologist Committee at Gustave Roussy, shared a post on LinkedIn:
“Superb progress for our BRAF lung cancer patients, but there’s still a long way to go…requiring collaborative work like that underway with the BOLERO consortium, Sandra Ortiz Cua, Julien Mazieres, so don’t hesitate to join us!”
“BRAF in NSCLC – From molecular mechanisms to clinical practice.”
Authors: Claudia Parisi, David Planchard
